How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Robots in Orthopaedic Surgery Market
- By Surgery Type: Knee Replacement, Hip Replacement, Spine Surgery, Shoulder Surgery, Trauma Surgery
- By Robot Type: Active Robots, Semi-active Robots, Passive Robots
- By Application: Preoperative Planning, Intraoperative Navigation, Postoperative Assessment
- By End User: Hospitals, Orthopaedic Clinics, Ambulatory Surgical Centers
- By Component: Hardware, Software, Services
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Knee Replacement leads By Surgery Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.174 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.182 →
Full report · locked preview
Everything inside the Robots in Orthopaedic Surgery Market report
A complete, evidence-based study - 12 chapters and 121 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Surgery Type 5
Robot Type 3
Application 3
End User 3
Component 3
Companies profiled
Stryker Corporation
Zimmer Biomet Holdings Inc.
Intuitive Surgical Inc.
Smith & Nephew plc
Medtronic plc
DePuy Synthes (Johnson & Johnson)
Mazor Robotics Ltd. (acquired by Medtronic)
Brainlab AG
Corin Group
OMNIlife science Inc.
Think Surgical Inc.
Aesculap Implant Systems (B. Braun Melsungen AG)
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Zimmer Biomet Holdings Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Intuitive Surgical Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Smith & Nephew plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →DePuy Synthes (Johnson & Johnson)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Mazor Robotics Ltd. (acquired by Medtronic)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Brainlab AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Corin Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →OMNIlife science Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Think Surgical Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Aesculap Implant Systems (B. Braun Melsungen AG)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Renishaw plc
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Globus Medical Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Conformis
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$3,221M by 2033 · 9.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Knee Replacement50.7
- Hip Replacement15.8
- Spine Surgery9.5
- Shoulder Surgery9.2
- Trauma Surgery14.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$517.1M → $1,049M · 9.2%
Europe$360.4M → $747.4M · 9.5%
Asia Pacific$329.1M → $676.4M · 9.4%
Latin America$203.7M → $398.5M · 8.7%
Middle East and Africa$156.7M → $292.2M · 8.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.382026
9.402027
9.412028
9.422029
9.432030
9.442031
9.442032
9.462033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Stryker Corporation21.6
- Zimmer Biomet Holdings Inc.12.9
- Intuitive Surgical Inc.6.6
- Smith & Nephew plc13.2
- Medtronic plc5.1
- DePuy Synthes (Johnson & Johnson)12.5
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Surgery Type11.6%
Robot Type11.5%
Application22.5%
End User30.9%
Component23.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.2
- Europe23.6
- Asia Pacific21.4
- Latin America12.6
- Middle East and Africa9.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Stryker Corporation | 92 | 92 | 95 | 94 | 84 | 79 | 89 |
| Zimmer Biomet Holdings Inc. | 80 | 87 | 79 | 92 | 85 | 88 | 85 |
| Intuitive Surgical Inc. | 70 | 76 | 74 | 82 | 79 | 66 | 75 |
| Smith & Nephew plc | 76 | 67 | 66 | 72 | 72 | 59 | 69 |
| Medtronic plc | 77 | 70 | 52 | 76 | 77 | 77 | 72 |
| DePuy Synthes (Johnson & Johnson) | 64 | 63 | 55 | 55 | 59 | 57 | 59 |
| Mazor Robotics Ltd. (acquired by Medtronic) | 41 | 49 | 57 | 44 | 49 | 46 | 48 |
| Brainlab AG | 59 | 39 | 41 | 53 | 53 | 52 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Stryker Corporation
- Zimmer Biomet Holdings Inc.
- Intuitive Surgical Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Stryker Corporation | ✓ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Zimmer Biomet Holdings Inc. | ✓ | ✓ | ✓ | ✓ | ◐ | ✓ |
| Intuitive Surgical Inc. | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Smith & Nephew plc | ✓ | ◐ | ✓ | ✓ | − | ◐ |
| Medtronic plc | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| DePuy Synthes (Johnson & Johnson) | ◐ | ◐ | ◐ | ◐ | − | ◐ |
| Mazor Robotics Ltd. (acquired by Medtronic) | ◐ | ◐ | − | − | ◐ | − |
| Brainlab AG | ◐ | − | − | ◐ | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Stryker Corporation89
2Zimmer Biomet Holdings Inc.85
3Intuitive Surgical Inc.75
4Medtronic plc72
5Smith & Nephew plc69
6DePuy Synthes (Johnson & Johnson)59
7Brainlab AG50
8Mazor Robotics Ltd. (acquired by Medtronic)48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Stryker CorporationZimmer Biomet Holdings Inc.
Challenger3
Strong scale, closing on the leaders.
Intuitive Surgical Inc.Smith & Nephew plcMedtronic plc
Contender1
Focused players with pockets of strength.
DePuy Synthes (Johnson & Johnson)
Niche2
Specialists in a single segment or region.
Mazor Robotics Ltd. (acquired by Medtronic)Brainlab AG
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Surgery Type in North America, then scale across Robots in Orthopaedic Surgery Market — a $85M beachhead inside a $1.29B market.
Beachhead (SOM)$85Mobtainable near-term
Serviceable (SAM)$510Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Knee Replacement
Best fit — highest urgency & budget in Surgery Type.
Economic buyer81 fit
Hip Replacement
Strong fit — clear ROI and a fast path to value.
End user67 fit
Spine Surgery
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Surgery Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Robot Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel27%
Digital / self-serve20%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Surgery Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Robots in Orthopaedic Surgery Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified21%
Evaluation12%
Closed-won8%
$19.2KCAC
$80KLTV
4.2:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Robots in Orthopaedic Surgery Market is a high-growth opportunity — $9.08B by 2033, compounding at 11.5%.
TAM · 2025$3.80Btoday
TAM · 2033$9.08Bforecast
CAGR11.5%2027–2033
Cumulative$55.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$9.08BTotal addressable market
SAM$3.24BServiceable available market
SOM$621MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.5% CAGR
Demand compounds through 2033, outpacing GDP across Surgery Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Surgery Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$9.08BLarge & growingTAM by 2033 at 11.5% CAGR
$3.24BServiceable nowreachable with today’s model
$621MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$7.09BBear7.5% CAGR
$9.08BBase11.5% CAGR
$11.6BBull15.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Robot Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Robots in Orthopaedic Surgery Market — a $1.05B market by 2033. Plan: grow share from 8.5% to 14.5%.
Market size · 2033$1.05Btotal addressable
Market CAGR6.9%2027–2033
Target share14.5%from 8.5% today
Revenue ambition$153Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.5% | 14.5% | Behind |
| Revenue | $93M | $153M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 36.1% | 39.7% | Behind |
| Customer retention | 91.2% | 96.9% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Surgery Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Robot Type capability
A defensible second engine — invest in Robot Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Surgery Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Robot Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $16M capacity & capability investment
- Greenlight bolt-on M&A in Robot Type
- Authorise North America expansion plan
- Fund R&D program for Surgery Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossBehind
- Input-cost & supply riskAt risk
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Robots in Orthopaedic Surgery Market conversation — a $2.92B market you can size, segment and defend in minutes.
Market size · 2033$2.92Btotal opportunity
Growth7.7%CAGR to 2033
Addressable buyers1,068+accounts in scope
Typical ROI6.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Surgery Type
Goal Grow share in Surgery Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.1×return on cost, year one
< 3 mopayback period
$51K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Stryker CorporationZimmer Biomet Holdings Inc.Intuitive Surgical Inc.Smith & Nephew plcMedtronic plcDePuy Synthes (Johnson & Johnson)Mazor Robotics Ltd. (acquired by Medtronic)Brainlab AG+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Robots in Orthopaedic Surgery Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Robots in Orthopaedic Surgery Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Robotic X-Ray System Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportRobotic Visualization System Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportRobotic Vascular Catheter System Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportRobotic Ultrasound Imaging Equipment Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportRobotic Surgical Instruments Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportRobotic Surgery Systemsfor Endometrial Cancer Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportRobotic Surgery Simulator Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportRobotic Surgery Service Market
Robotic Surgery Service Market is valued at USD 6.5 Billion in 2025 and is expected to reach US…
$6.5B market · 2025 base year
View reportRobotic Surgery for Endometrial Cancer Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportRobotic Surgery for Cervical Cancer Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportRobotic Surgery Consumables Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportRobotic Surgery Assistance System Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.